Thomas Goldner

Title: Thomas Goldner: Pharmaceutical Patent Inventor

Introduction

Thomas Goldner is an inventor associated with Velbert, Germany, and Aic246 AG & Co. KG. His patent work includes pharmaceutical compounds and formulations, including research concerning potential antiviral applications. The supplied information lists 4 patents associated with him.

Latest Patents

One of Goldner’s listed patents concerns a sodium salt monohydrate of a substituted 3,4-dihydroquinazoline compound. The invention describes the compound, its preparation, and its use.

Another listed patent concerns stable pharmaceutical compositions containing a related quinazoline acetic acid compound and sodium ions. The compositions are designed to be essentially free of complexing solubilizing agents, including polyethylene glycol, cyclodextrin, lysine, and arginine. The patent also describes preparation methods and potential therapeutic or prophylactic use, particularly as an antiviral against cytomegaloviruses.

Career Highlights

Goldner’s listed inventions focus on pharmaceutical chemistry, formulation stability, and methods for preparing medicinal compositions. His work is associated with Aic246 AG & Co. KG.

Collaborations

The supplied information identifies Helmut Buschmann and Jordi Carles Cerón Bertran as some of Goldner’s coworkers. Their names indicate professional connections, but the available details do not specify their roles in the listed patents.

Conclusion

Thomas Goldner’s listed patent portfolio reflects work on quinazoline-based pharmaceutical compounds and stable formulations, including inventions described for potential antiviral use.